Carl P. Decicco's most recent trade in Foghorn Therapeutics Inc was a trade of 104,310 Common Stock done at an average price of $3.7 . Disclosure was reported to the exchange on Dec. 9, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Foghorn Therapeutics Inc | Carl P. Decicco | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share. | 09 Dec 2021 | 104,310 | 362,707 | - | 3.7 | 388,033 | Common Stock |
| Foghorn Therapeutics Inc | Carl P. Decicco | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2021 | 76,892 | 186,571 | - | - | Stock Options (Right to buy) | |
| Foghorn Therapeutics Inc | Carl P. Decicco | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2021 | 27,418 | 34,273 | - | - | Stock Options (Right to buy) |